Sign in
Taking people in United StatesNo phase

Vena cava filter study for people with blood clots in the veins or lungs

Follows adults with a Celect Platinum filter to check its safety over time.

Key facts

Who runs it
Cook Research Incorporated
Where
Los Angeles, United StatesSee the siteAlso in 2 other countries, 6 sites
Trial code
Registry title
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
Status
Recruiting
People taking part
82 people, planned
Started
2 Jun 2025
Expected to end
Dec 2031
Type of study
Observational
Treatments tested
  • Celect Platinum Vena Cava Filter
Record updated
12 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have a procedure to place a Celect Platinum Vena Cava Filter. This is a filter put in a large vein to catch blood clots. The study collects data on how the filter works over up to 5 years.

Age
18 Years and older
Sex
All sexes
Earlier treatment
People who took part in the Cook MDR-2126 study before cannot join.

Main reasons for not taking part

  • The patient or their legal representative objects to the collection and use of the patient's data
  • The patient or their legal representative is not willing to sign the consent form
  • Took part in the Cook MDR-2126 study before

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • A patient dataset is deemed suitable for inclusion if the patient has a procedure where a Celect Platinum Vena Cava Filter is placed
  • Subject has not previously participated in the Cook MDR-2126 study

Who cannot take part

  • Patients will be excluded from enrollment if the patient or his/her legally authorized representative objects to collection and processing of his/her data or is not willing to sign the Informed Consent

Where in United States

Also in 2 other countries, 6 sites

  • Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Sabina AndersenTaking people

About the trial

What the trial wants to find out

This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio. Additionally, the study intends to evaluate longer-term (i.e., up to 5 years) outcome data while the filter is indwelling.

The group in the trial

  • Patients indicated for the placement of a Celect Platinum Vena Cava Filter

    Treatment: Celect Platinum Vena Cava Filter

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-Market Celect Platinum Vena Cava Filter and Günther Tulip Retrieval Set Study
Plain-language title
Vena cava filter study for people with blood clots in the veins or lungsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
12 November 2026